… a group of vaccinated patients with haematological malignancy and a comparison … vaccinated
patients with haematologic malignancies and bone marrow failure syndromes (two patients…

… marker of vaccine efficacy. These studies are the basis for vaccination recommendations …
to COVID-19 vaccination in patients with hematologic malignancies to build the evidence …

… for cancer patients were different for vaccination both during and after chemotherapy [17]. …
the vaccination of paediatric cancer patients. This document does not extend to patients who …

… uptake of influenza vaccination in patients with haematologic malignancies, with a vaccinal
rate of only 25.5%. The vaccinal coverage was particularly low in patients younger than 65 y …

… discuss the evidence for vaccination strategies in HCT patients, focusing on newer vaccine
… In hematology malignancy patients with diseases and treatments impacting B-cell immunity, …

… and various anti-cancer treatments [16], [17]. Taken together, … -19 vaccines in patients with
hematological malignancies are … rate of patients with hematological malignancies to different …

… in patients with HM fully vaccinated with two doses of anti-SARS-CoV-2 mRNA vaccine,
especially if … Moreover, a third vaccine does not induce seroconversion in patients who have not …

… of vaccine efficacy 15–17 . These studies are the basis for vaccination recommendations …
to COVID-19 vaccination in patients with haematological malignancy to build the evidence …

… confirmed those poor response rates in haematological patients compared to the overall …
% of patients after two doses of a SARS-CoV-2 mRNA vaccine. In patients with solid cancer we …

… ) infection in patients with haematological malignancies is … vaccination, successful anti-HBs
seroconversion following a three dose vaccine schedule has been reported in 57% of cancer …